240 related articles for article (PubMed ID: 23109061)
1. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
Scaini G; Comim CM; Oliveira GM; Pasquali MA; Quevedo J; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Bogo MR; Streck EL
J Inherit Metab Dis; 2013 Sep; 36(5):721-30. PubMed ID: 23109061
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
[TBL] [Abstract][Full Text] [Related]
3. Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.
Scaini G; Morais MO; Furlanetto CB; Kist LW; Pereira TC; Schuck PF; Ferreira GC; Pasquali MA; Gelain DP; Moreira JC; Bogo MR; Streck EL
Neurochem Res; 2015 May; 40(5):885-93. PubMed ID: 25681161
[TBL] [Abstract][Full Text] [Related]
4. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.
Scaini G; Mello-Santos LM; Furlanetto CB; Jeremias IC; Mina F; Schuck PF; Ferreira GC; Kist LW; Pereira TC; Bogo MR; Streck EL
Mol Neurobiol; 2013 Dec; 48(3):581-9. PubMed ID: 23559405
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats.
Wisniewski MS; Carvalho-Silva M; Gomes LM; Zapelini HG; Schuck PF; Ferreira GC; Scaini G; Streck EL
Metab Brain Dis; 2016 Apr; 31(2):377-83. PubMed ID: 26586008
[TBL] [Abstract][Full Text] [Related]
8. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats.
Wessler LB; de Miranda Ramos V; Bittencourt Pasquali MA; Fonseca Moreira JC; de Oliveira J; Scaini G; Streck EL
Int J Dev Neurosci; 2019 Nov; 78():210-214. PubMed ID: 31330240
[TBL] [Abstract][Full Text] [Related]
9. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
[TBL] [Abstract][Full Text] [Related]
10. DNA damage in an animal model of maple syrup urine disease.
Scaini G; Jeremias IC; Morais MO; Borges GD; Munhoz BP; Leffa DD; Andrade VM; Schuck PF; Ferreira GC; Streck EL
Mol Genet Metab; 2012 Jun; 106(2):169-74. PubMed ID: 22560665
[TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
[TBL] [Abstract][Full Text] [Related]
12. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease.
Scaini G; de Rochi N; Jeremias IC; Deroza PF; Zugno AI; Pereira TC; Oliveira GM; Kist LW; Bogo MR; Schuck PF; Ferreira GC; Streck EL
Mol Neurobiol; 2012 Apr; 45(2):279-86. PubMed ID: 22328136
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.
Scaini G; Morais MO; Galant LS; Vuolo F; Dall'Igna DM; Pasquali MA; Ramos VM; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Soriano FG; Dal-Pizzol F; Streck EL
Mol Neurobiol; 2014 Oct; 50(2):358-67. PubMed ID: 24390570
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
Mescka CP; de Moura Coelho D; Sitta A; Catarino F; Donida B; Rosa AP; Gonzalez EA; Pinheiro CV; Poletto F; Baldo G; Dutra-Filho CS; Vargas CR
Metab Brain Dis; 2021 Jun; 36(5):1015-1027. PubMed ID: 33620579
[TBL] [Abstract][Full Text] [Related]
17. Memantine Improves Memory and Neurochemical Damage in a Model of Maple Syrup Urine Disease.
Lemos IDS; Torres CA; Alano CG; Matiola RT; de Figueiredo Seldenreich R; Padilha APZ; De Pieri E; Effting PS; Machado-De-Ávila RA; Réus GZ; Leipnitz G; Streck EL
Neurochem Res; 2024 Mar; 49(3):758-770. PubMed ID: 38104040
[TBL] [Abstract][Full Text] [Related]
18. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.
Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL
Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
